Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 2, 2004, Pages 93-100

  Lintula, S ^a   Vesalainen, S ^a   Rannikko, A ^a   Zhang, W M ^a   Finne, P ^a   Stenman, J ^a,b   Stenman, U H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

Prostate cancer; Prostatic surgery; PSA mRNA; RT PCR

Indexed keywords

ANTIANDROGEN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HORMONAL THERAPY; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATE SURGERY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION;

CELL LINE; FEMALE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 1842865791     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410004191     Document Type: Article

References (26)

1. Su SL, Boynton AL, Holmes EH, Elgamal AA, Murphy GP. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. [Review]. Semin Surg Oncol 2000; 18: 17-28.
2. Smith MR, Biggar S, Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 1995; 55: 2640-4.
3. Lintula S, Stenman U-H. The expression of prostate-specific membrane antigen in peripheral blood leukocytes. J Urol 1997; 157: 1969-72.
4. Corey E, Arfman EA, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997; 43: 443-52.
5. Stenman J, Lintula S, Rissanen O, Finne P, Hedström J, Palotie A, Orpana A. Quantitative detection of low-copy-number mRNAs differing at single nucleotide positions. BioTechniques 2003; 34: 172-7.
6. Verhagen M, Ioannou PC, Christopoulos TK. Quantification of prostate-specific antigen mRNA by coamplification with a recombinant RNA internal standard and microtiter well-based hybridization. Clin Chem 1998; 44: 1170-6.
7. Ylikoski A, Pettersson K, Nurmi J, Irjala K, Karp M, Lilja H, Lövgren T, Nurmi M. Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease. Clin Chem 2002; 48: 1265-71.
8. Moreno JG, O'Hara SM, Long JP, Veltri RW, Ning X, Alexander AA, Gomella LG. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology 1997; 49: 515-20.
9. Oefelein MG, Ignatoff JM, Clemens JQ, Watkin W, Kaul KL. Clinical and molecular follow-up after radical retropubic prostatectomy. J Urol 1999; 162: 307-10.
10. Heung YM, Walsh K, Sriprasad S, Mulvin D, Sherwood RA. The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate. Br J Urol Int 2000; 85: 65-9.
11. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman U-H. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995; 41: 182-6.
12. Lundwall A, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 1987; 214: 317-22.
13. Monne M, Moreno J, Mele C, Mulholland G, Gomella L. A comparative analysis of prostate specific antigen gene sequence in benign and malignant prostate tissue. Unpublished GeneBank Accession U17040.
14. Riegman PH, Klaassen P, van der Korput JA, Romijn JC, Trapman J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 1988; 155: 181-8.
15. Heuze-Vourc'h N, Leblond V, Olayat S, Gauthier F, Courty Y. Characterization of PSA-RP2, a protein related to prostate-specific antigen and encoded by alternative hKLK3 transcripts. Eur J Biochem 2001; 268: 4408-13.
16. Heuze-Vourc'h N, Courty Y. Complex alternative splicing of the hKLK3 gene coding for the tumour marker PSA (prostate-specific-antigen). Unpublished. Genebank Accession AJ459784
17. Heuze N, Olayat S, Gutman N, Zani ML, Courty Y. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. Cancer Res 1999; 59: 2820-4.
18. Tanaka T, Isono T, Yoshiki T, Yuasa T, Okada Y. A novel form of prostate-specific antigen transcript produced by alternative splicing. Cancer Res 2000; 60: 56-9.
19. David A, Mabjeesh N, Azar I, Biton S, Engel S, Bernstein J, Romano J, Avidor Y, Waks T, Eshhar Z, Langer SZ, Lifschitz-Mercer B, Matzkin H, Rotman G, Toporik A, Savitsky K, Mintz L. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem 2002; 277: 18084-90.
20. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole K, McMahon D, Benson MC, Buttyan R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43: 765-75.
21. Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, Olsson CA. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995; 75: 1642-8.
22. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, Rudolph B, Schnorr D, Loening SA. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer 1997; 70: 52-6.
23. Ogawa O, Iinuma M, Sato K, Sasaki R, Shimoda N, Satoh S, Kato T. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy. Urol Res 1999; 27: 291-6.
24. Hara N, Kasahara T, Kawasaki T, Bilim V, Tomita Y, Obara K, Takahashi K. Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy. Br J Cancer 2001; 85: 557-62.
25. Price DK, Clontz DR, Woodard WL 3rd, Kaufman JS, Daniels JM, Stolzenberg SJ, Teigland CM. Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay. Urology 1998; 52: 261-6.
26. Stenman J, Orpana A. Accuracy in amplification. Nat Biotechnol 2001; 19: 1011-2.